Capital Union Investments
Capital Union Investments Limited is a venture capital firm based in Hong Kong, with additional offices in China, the United States, the United Kingdom, and India. The firm specializes in providing capital across various stages, including seed and angel investing, startups, series A, pre-IPO, debt financing, mezzanine, and bridge financing. It adopts a sector-agnostic approach, having invested in diverse fields such as technology, medical, food and beverage, property, entertainment, financial technology, and e-commerce. Capital Union Investments focuses on identifying and supporting leaders and innovators whose businesses can thrive in the Asian market, leveraging its unique investment insights, local expertise, and operational capabilities to create value.
Dash Living is the new generation of rental solutions in Asia for urban professionals. Through our coliving, serviced apartment, hotel & home-sharing products, our mission is to create a global accommodation community through sharing economies and tech, empowering today's hyper-mobile, tech-savvy millennials to live in the most expensive cities in the world. Dash offers panoramic, all-inclusive rental options across over 1,000 units that we manage. Our products enable you to thrive in busy cities like Hong Kong & Singapore - from daily stays with Dash Hotels, local experiences in shared homes with Dashare, or short to long term stays in serviced apartments with Dash Suites or the community living with Dash Coliving.
Surkus, Inc. operates a mobile application and online platform focused on experiential marketing, connecting businesses with targeted audiences to enhance brand engagement. Founded in 2014 and headquartered in West Hollywood, California, with additional offices in Abu Dhabi and Hong Kong, the company curates groups of tastemakers for various client events, including nightlife, comedy shows, product launches, and digital campaigns. Members of the platform receive tailored invitations to discover and participate in experiences they enjoy, while businesses gain access to authentic feedback and content creation in exchange for free or discounted products. Surkus's performance-based model minimizes risk for clients, as they only pay for successful engagements, fostering meaningful interactions that drive brand awareness and sales. The platform also facilitates communication between clients and members before, during, and after campaigns, enhancing overall engagement and experience.
Prenetics is a genetic and diagnostic health testing company that leverages DNA sequencing technology to help individuals identify health risks. Founded in 2009 and headquartered in Quarry Bay, Hong Kong, Prenetics empowers users with insights into how their genetics influence diet, drug responses, and disease risks, enabling proactive health management. The company operates two primary brands, CircleDNA in Asia and DNAFit, offering services such as a digital coaching app and the ONEdna screening test, which provides actionable recommendations based on genetic analysis. Additionally, Prenetics specializes in pharmacogenomics through its iGenes PGx test, which aids healthcare providers in determining the most suitable medications and dosages for patients based on their genetic profiles, particularly for cardiovascular and psychiatric conditions. The company has formed strategic partnerships with The Lippo Group and New Horizon Health Limited.
Prenetics is a genetic and diagnostic health testing company that leverages DNA sequencing technology to help individuals identify health risks. Founded in 2009 and headquartered in Quarry Bay, Hong Kong, Prenetics empowers users with insights into how their genetics influence diet, drug responses, and disease risks, enabling proactive health management. The company operates two primary brands, CircleDNA in Asia and DNAFit, offering services such as a digital coaching app and the ONEdna screening test, which provides actionable recommendations based on genetic analysis. Additionally, Prenetics specializes in pharmacogenomics through its iGenes PGx test, which aids healthcare providers in determining the most suitable medications and dosages for patients based on their genetic profiles, particularly for cardiovascular and psychiatric conditions. The company has formed strategic partnerships with The Lippo Group and New Horizon Health Limited.